Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Clinical Laboratory|January 14, 2012
Peptidyl-arginine deiminase: an additional marker of rheumatoid arthritisPranab S Basu, Ramdhan Majhi, Samit Ghosal, et al.
Indian Journal of Endocrinology and Metabolism|October 7, 2014
Clinical experience of switching from glargine or neutral protamine Hagedorn insulin to insulin detemir in type 2 diabetes: Observations from the Indian cohort in the A1chieve studySubhash Kumar Wangnoo, Samit Ghosal, Shahid Akhtar, et al.
Diabetes & Metabolic Syndrome|July 1, 2020
Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: A cohort analysisSamit Ghosal, Bhavya Arora, Koel Dutta, et al.
Indian Journal of Endocrinology and Metabolism|November 22, 2016
Liraglutide effect and action in diabetes-In (LEAD-In): A prospective observational study assessing safety and effectiveness of liraglutide in patients with type 2 diabetes mellitus treated under routine clinical practice conditions in IndiaSubhash Kumar Wangnoo, Surender Kumar, Arpandev Bhattacharyya, et al.
Indian Journal of Endocrinology and Metabolism|April 18, 2014
Treat-to-target trials in diabetesSubhash K Wangnoo, Bipin Sethi, Rakesh K Sahay, et al.
Diabetes & Metabolic Syndrome|January 10, 2015
Critical appraisal of the recent data published on the link between insulin and cancerSamit Ghosal, Jeff Stephens, Annalie Van Deventer, et al.
Cureus|December 9, 2024
Harnessing Digital Initiatives for Improved Health Outcomes in Diabetes Management: An Observational Patient ProgramBipin Sethi, Krishna Seshadri, Vaishali Deshmukh, et al.
Diabetes & Metabolic Syndrome|August 14, 2019
Screen time and metabolic syndrome among expatriate adolescents in the United Arab EmiratesMoien Ab Khan, Syed M Shah, Abdullah Shehab, et al.
Diabetes & Metabolic Syndrome|June 2, 2022
The role of oral semaglutide in managing type 2 diabetes in Indian clinical settings: Addressing the unmet needsShashank R Joshi, Rajesh Rajput, Subhankar Chowdhury, et al.
Cureus|July 17, 2026
Screening for Hepatic Steatosis and Fibrosis Among Physicians Attending the Integrated Diabetes and Endocrine Academy Conference: A Cross-Sectional StudyBinayak Sinha, Samit Ghosal, Soumyabrata RoyChaudhuri, et al.
Pageof 6